Literature DB >> 27126737

Neuropharmacology of N,N-dimethyltryptamine.

Theresa M Carbonaro1, Michael B Gatch2.   

Abstract

N,N-dimethyltryptamine (DMT) is an indole alkaloid widely found in plants and animals. It is best known for producing brief and intense psychedelic effects when ingested. Increasing evidence suggests that endogenous DMT plays important roles for a number of processes in the periphery and central nervous system, and may act as a neurotransmitter. This paper reviews the current literature of both the recreational use of DMT and its potential roles as an endogenous neurotransmitter. Pharmacokinetics, mechanisms of action in the periphery and central nervous system, clinical uses and adverse effects are also reviewed. DMT appears to have limited neurotoxicity and other adverse effects except for intense cardiovascular effects when administered intravenously in large doses. Because of its role in nervous system signaling, DMT may be a useful experimental tool in exploring how the brain works, and may also be a useful clinical tool for treatment of anxiety and psychosis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hallucinogen; N,N-dimethyltryptamine; Neurotransmitter; Psychiatric disorder

Mesh:

Substances:

Year:  2016        PMID: 27126737      PMCID: PMC5048497          DOI: 10.1016/j.brainresbull.2016.04.016

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  200 in total

Review 1.  Health status of ayahuasca users.

Authors:  Paulo Cesar Ribeiro Barbosa; Suely Mizumoto; Michael P Bogenschutz; Rick J Strassman
Journal:  Drug Test Anal       Date:  2012-07-04       Impact factor: 3.345

2.  Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex.

Authors:  Elizabeth A Pehek; Christine Nocjar; Bryan L Roth; Tara A Byrd; Omar S Mabrouk
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

3.  Indolethylamine-N-methyltransferase in developing rabbit lung.

Authors:  R L Lin; S Sargeant; N Narasimhachari
Journal:  Dev Psychobiol       Date:  1974-09       Impact factor: 3.038

4.  Determination and physiological disposition of dimethyltryptamine and diethyltryptamine in rat brain, liver and plasma.

Authors:  I Cohen; W H Vogel
Journal:  Biochem Pharmacol       Date:  1972-04-15       Impact factor: 5.858

5.  Rabbit serum monoamine oxidase. II. Determinants of substrate specificity.

Authors:  C M McEwen; A J Sober
Journal:  J Biol Chem       Date:  1967-07-10       Impact factor: 5.157

6.  The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.

Authors:  J Cartmell; J A Monn; D D Schoepp
Journal:  J Pharmacol Exp Ther       Date:  1999-10       Impact factor: 4.030

7.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Authors:  R J Strassman; C R Qualls; E H Uhlenhuth; R Kellner
Journal:  Arch Gen Psychiatry       Date:  1994-02

8.  Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects.

Authors:  R J Strassman; C R Qualls
Journal:  Arch Gen Psychiatry       Date:  1994-02

Review 9.  Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.

Authors:  M Caraglia; M Marra; P Tagliaferri; S W J Lamberts; S Zappavigna; G Misso; F Cavagnini; G Facchini; A Abbruzzese; L J Hofland; G Vitale
Journal:  Curr Cancer Drug Targets       Date:  2009-08-01       Impact factor: 3.428

10.  Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.

Authors:  R J Strassman; C R Qualls; L M Berg
Journal:  Biol Psychiatry       Date:  1996-05-01       Impact factor: 13.382

View more
  26 in total

1.  Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

2.  Evidence on the impairing effects of Ayahuasca on fear memory reconsolidation.

Authors:  Daiane Momo Daneluz; Jeferson Machado Batista Sohn; Gabriela O Silveira; Maurício Yonamine; Cristina Aparecida Stern
Journal:  Psychopharmacology (Berl)       Date:  2022-09-07       Impact factor: 4.415

3.  Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience.

Authors:  David Wyndham Lawrence; Robin Carhart-Harris; Roland Griffiths; Christopher Timmermann
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

Review 4.  N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.

Authors:  Edward James; Joachim Keppler; Thomas L Robertshaw; Ben Sessa
Journal:  Hum Psychopharmacol       Date:  2022-02-17       Impact factor: 2.130

5.  Ayahuasca for the Treatment of Depression.

Authors:  Fernanda Palhano-Fontes; Bruno Lobão Soares; Nicole Leite Galvão-Coelho; Emerson Arcoverde; Draulio B Araujo
Journal:  Curr Top Behav Neurosci       Date:  2022

6.  Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection.

Authors:  Feihe Ma; Liu Yang; Zhuorui Sun; Jinjin Chen; Xuehui Rui; Zachary Glass; Qiaobing Xu
Journal:  Sci Adv       Date:  2020-07-24       Impact factor: 14.136

Review 7.  Biosynthesis and synthetic biology of psychoactive natural products.

Authors:  Cooper S Jamieson; Joshua Misa; Yi Tang; John M Billingsley
Journal:  Chem Soc Rev       Date:  2021-06-21       Impact factor: 60.615

Review 8.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

Review 9.  N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.

Authors:  Steven A Barker
Journal:  Front Neurosci       Date:  2018-08-06       Impact factor: 4.677

10.  It's Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish.

Authors:  Bruno Lobao-Soares; Paulianny Eduardo-da-Silva; Hugo Amarilha; Jaquelinne Pinheiro-da-Silva; Priscila F Silva; Ana Carolina Luchiari
Journal:  Front Behav Neurosci       Date:  2018-08-27       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.